MELANOLYTE TX
Live / Registered — Registered and renewed (as of 19 Oct 2020)
What this means for you
Registered since 08 Feb 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Feb 2021).
Record
- Serial number
- 77866504
- Registration number
- 3917914
- Mark type
- Stylized text
- Filed
- 06 Nov 2009
- Published for opposition
- 13 Jul 2010
- Registered
- 08 Feb 2011
- Next maintenance due
- 08 Feb 2021
- Attorney of record
- Bradlee Frazer
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Non-medicated skin care ingredients sold as an integral component of topically applied cosmetics, namely, [ skin creams, ] lotions [, powders and gels ]
- Class 005 — Pharmaceuticals: [ Medicated skin care ingredients sold as an integral component of topically applied nutraceuticals and dermatologicals, namely, creams, lotions, oils and gels for the treatment of skin conditions ]
Owner
- Episciences Inc., Boise, ID, US
- Episciences Inc., Boise, ID, US
- Episciences Inc., Boise, ID, US
Prosecution history
- 19 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 19 Oct 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Oct 2020 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 19 Oct 2020 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 16 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 16 Oct 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 07 Oct 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 05 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 03 Apr 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 03 Apr 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Mar 2020 — TEAS SECTION 8 & 9 RECEIVED
- 13 Mar 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Mar 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Mar 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Feb 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED